**Background:** Hospital-acquired pressure injuries (HAPI) are a significant quality-of-care concern in intensive care units, particularly among critically ill patients with reduced mobility. During the COVID-19 pandemic, the prone position was widely used to improve oxygenation in patients with severe ARDS. However, prone positioning places pressure on anterior body regions, potentially increasing HAPI risk. This study aimed to identify the incidence and factors associated with HAPI in COVID-19 patients placed in the prone position in the ICU.
**Methods:** This retrospective cohort study was conducted in an ICU of a tertiary university hospital. All patients admitted from May to September 2020 with confirmed COVID-19 (positive real-time PCR) who were placed in the prone position during ICU admission were included. Patients with pre-existing HAPI at admission were excluded. Data were collected from electronic medical records across three domains: (1) demographics and baseline characteristics (sex, age, skin color, comorbidities, Braden Risk Scale score, SAPS III score, ICU length of stay); (2) risk factors (sedation, vasoactive drugs, prone position duration, laboratory values, BMI, mechanical ventilation/tracheostomy, P/F ratio, enteral nutrition, central venous catheter, urinary catheter); and (3) HAPI occurrence, location, and stage according to the International Classification System. Statistical analysis used Student's t-test for quantitative variables and Fisher's exact test for qualitative variables. Variables with P<0.20 in univariate analysis were entered into a logistic regression model. Significance was set at α=0.05.
**Key Results:** Of 204 COVID-19 patients evaluated, 84 were included (required prone positioning). None had HAPI prior to ICU admission. Fifty-two patients (62%) developed HAPI during hospitalization. In univariate analysis, factors significantly associated with HAPI were: tracheostomy (81.8% vs. 54.8%, P=0.021), immunosuppression (90.9% vs. 57.5%, P=0.045), longer ICU length of stay (27.3 vs. 16.8 days, P=0.001), lower Braden Scale score (10.8 vs. 12.6, P=0.029), and lactate dehydrogenase levels (791.4 vs. 1076.7, P=0.051). In multivariate logistic regression, only Braden Scale (OR 0.84, P=0.031, 95% CI 0.714–0.984) and ICU length of stay (OR 1.12, P=0.008, 95% CI 1.028–1.209) remained independently associated with HAPI. Each additional day of hospitalization increased HAPI odds by 1.12 times. Among the 52 patients with HAPI, 27 (51.9%) had one lesion, 13 (25.0%) had two, and the remainder had three or more. A total of 105 HAPI lesions were documented. The most common sites were sacral region (25, 23.9%), gluteus (13, 12.4%), thorax (10, 9.5%), and calcaneus (9, 8.6%). Twenty-six patients (50%) had HAPI in sites potentially associated with prone positioning. Only one lesion was classified as stage IV (sacral region); the remainder were stage I, II, III, or unclassifiable.
**Clinical Implications:** This study demonstrates a high incidence (62%) of HAPI in critically ill COVID-19 patients requiring prone positioning, substantially higher than pre-pandemic rates reported in the literature (46.3–57.1%). The Braden Scale proved to be a useful predictor of HAPI risk even in this specific population, and longer ICU stays independently increased risk. Notably, time spent in the prone position was not significantly associated with HAPI, possibly due to the use of specialized cushions. These findings underscore the importance of implementing structured prevention protocols that address both dorsal and anterior pressure points, particularly given the challenges of frequent repositioning during periods of staff overload. The study is limited by its single-center, retrospective design and reliance on medical record documentation.